AtriCure, Inc.
ATRC
$40.15
-$0.74-1.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.75% | 0.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.75% | 0.53% | |||
| Cost of Revenue | 9.51% | -9.17% | |||
| Gross Profit | 8.52% | 3.77% | |||
| SG&A Expenses | -2.35% | 7.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.29% | 1.97% | |||
| Operating Income | 1,737.45% | -78.88% | |||
| Income Before Tax | 2,292.39% | -83.31% | |||
| Income Tax Expenses | 64.69% | -52.65% | |||
| Earnings from Continuing Operations | 8,191.67% | -93.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8,191.67% | -93.85% | |||
| EBIT | 1,737.45% | -78.88% | |||
| EBITDA | 158.18% | -23.68% | |||
| EPS Basic | 8,263.64% | -93.99% | |||
| Normalized Basic EPS | 2,274.51% | -83.44% | |||
| EPS Diluted | 8,081.82% | -93.87% | |||
| Normalized Diluted EPS | 2,312.00% | -83.44% | |||
| Average Basic Shares Outstanding | 0.69% | 0.78% | |||
| Average Diluted Shares Outstanding | -0.36% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||